Reports
PhRMA’s False Claims About “Unintended Consequences” of the Inflation Reduction Act
Between September 2024 and mid-January 2025, PhRMA spent over $235,800 on 128 Meta ads to attack the Inflation Reduction Act’s drug price reforms. Click here to download full report